Traditional Chinese medicine has a long history in Japan, and it has developed rapidly in recent years, with significant economic value. Several policies have been issued to support the overseas development of traditional Chinese medicine culture since the Chinese government announced "The Belt and Road Initiative" policy in 2013. Against the backdrop of "The Belt and Road Initiative," the development of traditional Chinese medicine in Japan is hampered by issues such as the Japanese government's constant shift in attitude towards participation in "The Belt and Road Initiative" and the Japanese medical community's immortality of "de-Sinicization" of traditional Chinese medicine. At the same time, it has a strong mass foundation of traditional Chinese medicine in Japan, which is in line with Japan's current medical and health needs, as well as a significant market and economic benefits and other opportunities, to investigate the development of traditional Chinese medicine in Japan against the backdrop of "The Belt and Road Initiative" to explore a higher level of growth for traditional Chinese medicine internationalisation.

Shao Yuanyuan, Guo Meiyan. Research on the Development of Japanese Traditional Chinese Medicine under the Background of The Belt and Road Initiative. International Journal of Frontiers in Medicine (2023), Vol. 5, Issue 9: 96-100. https://doi.org/10.25236/IJFM.2023.050916.

[1] KOSO-TOYO, GUO Xiumei. The trajectory of the formation of Chinese medicine in Japan[J]. Chinese Journal of the History of Science and Technology, 2012,33(01): 80-85. 

[2] Xiao Yueyuan, Yang Zhibo. Insights from the development of Chinese medicine in Japan[J]. Chinese Journal of Integrative Dermatology and Venereology, 2018,17(06): 554-558.

[3] Cui Yuanyue, Hu Lingjuan, Meng Haoting. Trade in Chinese medicine services under the "Belt and Road" initiative[J]. China Medicine Herald, 2018,15(04): 108-112. 

[4] Liang, Weixiong. Prospects of Traditional Chinese Medicine in the 21st Century from the Current Situation of Chinese Medicine in Japan[J]. Journal of Guangzhou University of Traditional Chinese Medicine, 2002(01): 6-7.

[5] Li Danxi, Tian Ding, Meng Hao, et al. A survey on modern Chinese medicine education in Japanese medical schools[J]. World Science and Technology (Modernization of Traditional Chinese Medicine), 2012,14(06): 2307-2328.

[6] Gao Pengfei, Zongxing Jiawei, X. A., et al. Japanese-Chinese medical education. Japan Toyo Medical Journal, 2012, 63 (2): 131-137.

[7] Chen Zhaohui, Huang Chunchun, He Lan. Japanese patent analysis and comparison of Chinese and Japanese patent systems. Chinese herbal medicine, 2006 (02): 298-300.

[8] Xin Xue, Huang Dazhi. A Comparative Study of New Drugs in Chinese and Japanese Classical Prescriptions from the Perspective of Patent Analysis [J]. Journal of Chinese New Drugs, 2020, 29 (05): 487-493.

[9] Wu Taihang. A Brief Analysis of Japan's Path Selection for the Belt and Road Initiative [J]. Southern Journal, 2019 (10): 41-43.

[10] Li Zhenfei, Zhai Dongsheng, Feng Xiuzhen, et al. Collaborative Analysis of Internationalized Intellectual Property Rights of Traditional Chinese Medicine Enterprises: Taking Jincun Co., Ltd. and Beijing Tongrentang as examples [J]. Intelligence Magazine, 2015, 34 (07): 105-109.

[11] Su Rui, Su Youzhu, Su Qingmin, et al. Northeast Asian States along the Belt and Road Traditional Chinese Medicine Policies and Market Survey [J]. Global Traditional Chinese Medicine, 2018, 11 (12): 2008-2010.

[12] MINISTRY of HEALTH LAW. Annual Health, Labour and Welfare Report 2016 [EB/OL]. https://mhlw.go.jp/english/wp/wp-hw10/dl/02e.pdf.

[13] Xing Ou, Zhang Jian. The Status, Policy and Enlightenment of Japan’s Health Industry Development under the Background of Aging[J]. Health Economy of China, 2020, 39 (03): 94-96.

[14] Wang Chunli, Gao Yuehong, Huang Yaoqing, et al. Chinese Medicine Industry Structure and Future Outlook [J]. Journal of Chinese New Drugs, 2020, 29 (16): 1845-1850.

[15] Chen Ning. Traditional knowledge can no longer be "brought in" -- Expert Talk on the Protection of Traditional Chinese Medicine [J]. Hospital Management Forum, 2005 (06): 40-42.